RxA’s Trusted Partners in Health Fall Professional Development Virtual Conference

In this presentation, clinical rheumatologist Dr. Stephanie Keeling will describe what lupus is and how it is diagnosed. She will review the treatments for lupus based on the disease phenotype and will outline the impact of lupus on life trajectories.

The Pharmacist’s Guide to the Gut: Fibre, Probiotics, and Beyond will provide you with practical, evidence-based insights into the gut microbiome and its relevance to pharmacy practice. The session will explore the role of diet, review clinical indications for probiotics, and highlight how medications influence the gut microbiome. Attendees will gain practical strategies to counsel patients on microbiome-supportive approaches.

Join Clinical Professor and oral and maxillofacial surgeon, Dr. Saranjeev Lahl, for an engaging presentation on the evolving landscape of Human Papilloma Virus (HPV)-related head and neck cancers in Canada.

Through this session, participants will gain an in-depth understanding of the burden of HPV-related head and neck disease, as well as the patient journey following a diagnosis. Dr. Lahl will also highlight key clinical considerations, including vaccine indications and their role in prevention.

Menopause is a highly individual experience. Up to 75% of women will experience symptoms, about 25% face them with such intensity that they seek treatment. Yet far too many individuals go without the support they need. Stigma, misinformation, and lingering fears around menopausal hormone therapy remain barriers to care. As a result, many women feel isolated, misunderstood, or hesitant to ask for help. Pharmacists play a vital role in changing this narrative. This session will equip you to engage meaningfully with women, provide clear, evidence-informed guidance, and support them in navigating the complex landscape of menopause misinformation.

Pharmacists can often identify the people we are caring for who live with diabetes. But how many of us know which of the one in three people with diabetes that we are caring for who also have diabetic kidney disease? This session will share how pharmacists can actively prevent and manage the chronic condition of diabetic kidney disease through timely, wisely-chosen screening, the use of evidence-informed cardiorenal protective therapies when indicated and the use of documentation to support interprofessional collaboration and care of the individual living with diabetic kidney disease.

In this session, pharmacists Dr. Ross Tsuyuki and Dr. Stephanie Gysel will explore the updated Hypertension Canada Primary Care Guidelines, highlighting key aspects that are particularly relevant to pharmacy practice. Through case studies, they will demonstrate practical implementation strategies and present the supporting evidence for the role of pharmacists in hypertension management.